Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report

Descripción del Articulo

Objectives: To determine best dilutions and concentrations of ELISA test to detect IgE antibody, its sensitivity and specificityand predictive value in patients with cistyc echinococcosis. To analyze the relationship between IgE specific antibody level andalbendazole medical treatment response in a...

Descripción completa

Detalles Bibliográficos
Autores: Vildózola, Herman, Espinoza, Irma, Roldan, William H.
Formato: artículo
Fecha de Publicación:2012
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:revistasinvestigacion.unmsm.edu.pe:article/808
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/808
Nivel de acceso:acceso abierto
Materia:ELISA IgE
equinococosis quistica
albendazol.
IgE ELISA
cystic echinococcosis
albendazole.
id REVUNMSM_7888d06b8262c0022203b5970049619a
oai_identifier_str oai:revistasinvestigacion.unmsm.edu.pe:article/808
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
dc.title.none.fl_str_mv Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
Estandarización de una prueba de ELISA para detectar anticuerpos IgE en pacientes con equinococosis quistica y su utilidad en el diagnóstico y seguimiento de pacientes tratados con albendazol: reporte preliminar
title Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
spellingShingle Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
Vildózola, Herman
ELISA IgE
equinococosis quistica
albendazol.
IgE ELISA
cystic echinococcosis
albendazole.
title_short Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
title_full Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
title_fullStr Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
title_full_unstemmed Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
title_sort Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary report
dc.creator.none.fl_str_mv Vildózola, Herman
Espinoza, Irma
Roldan, William H.
author Vildózola, Herman
author_facet Vildózola, Herman
Espinoza, Irma
Roldan, William H.
author_role author
author2 Espinoza, Irma
Roldan, William H.
author2_role author
author
dc.subject.none.fl_str_mv ELISA IgE
equinococosis quistica
albendazol.
IgE ELISA
cystic echinococcosis
albendazole.
topic ELISA IgE
equinococosis quistica
albendazol.
IgE ELISA
cystic echinococcosis
albendazole.
description Objectives: To determine best dilutions and concentrations of ELISA test to detect IgE antibody, its sensitivity and specificityand predictive value in patients with cistyc echinococcosis. To analyze the relationship between IgE specific antibody level andalbendazole medical treatment response in a period over one year after completion of albendazole therapy. Design: Quasiexperimentalstudy with control group. Setting: Instituto de Medicina Tropical Daniel A. Carrion, Faculty of Medicine, UNMSM,Lima, Peru. Study material: IgE antibody ELISA test. Interventions: IgE antibody ELISA test standardization with preexperimentalpretest and post test in one group to assess its value in diagnosis and post-treatment of patients with hepatic hydatid cysts treatedwith albendazole. For ELISA test standardization we used serum from five patients with clinical and immunological diagnosis ofcystic echinococcosis; to test sensitivity and specificity sera of 30 apparently healthy subjects were studied; to determine crossreactions16 serum samples from patients with other helminth infections (ascariasis, strongiloidiasis, toxocariasis, trichuriasis,hymenolepiasis cysticercosis and taeniasis) were used. For diagnosis and post-treatment evaluation of cystic echinocococosisserum from 17 patients was studied. Main outcome measures: Standarized ELISA test sensitivity and specificity to detect IgEantibodies. Results: Sensitivity and specificity of standardized ELISA test to detect IgE antibody were respectively 95.6% and 100%.Patients with hepatic hydatid cyst considered cured uniformly showed lower levels of IgE antibody even to negativization. There wasincrease of IgE levels in patients who had recurrence of hepatic cystic disease. Conclusions: This study found excellent sensitivity andspecificity of ELISA test for cystic echinococcosis IgE antibodies. Healing of cysts coincided with progressive decrease in IgE levelsthat could reach negativization after one year post-treatment and was useful to detect recurrence. Persistence of IgE high levels inpatients treated medically was indicative of no response to treatment. As sample size was not large, it seems necessary to continueinvestigation to confirm these results.
publishDate 2012
dc.date.none.fl_str_mv 2012-03-19
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
medicina tropical
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/808
10.15381/anales.v73i1.808
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/808
identifier_str_mv 10.15381/anales.v73i1.808
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/808/645
dc.rights.none.fl_str_mv Derechos de autor 2012 Herman Vildózola, Irma Espinoza, William H. Roldan
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2012 Herman Vildózola, Irma Espinoza, William H. Roldan
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 73 No. 1 (2012); 35-41
Anales de la Facultad de Medicina; Vol. 73 Núm. 1 (2012); 35-41
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1848424299749179392
spelling Standarization of an ELISA test to detect IgE antibodies in patients with cystic echinococcosis and its use in diagnosis and follow-up of patients treated with albendazol: preliminary reportEstandarización de una prueba de ELISA para detectar anticuerpos IgE en pacientes con equinococosis quistica y su utilidad en el diagnóstico y seguimiento de pacientes tratados con albendazol: reporte preliminarVildózola, HermanEspinoza, IrmaRoldan, William H.ELISA IgEequinococosis quisticaalbendazol.IgE ELISAcystic echinococcosisalbendazole.Objectives: To determine best dilutions and concentrations of ELISA test to detect IgE antibody, its sensitivity and specificityand predictive value in patients with cistyc echinococcosis. To analyze the relationship between IgE specific antibody level andalbendazole medical treatment response in a period over one year after completion of albendazole therapy. Design: Quasiexperimentalstudy with control group. Setting: Instituto de Medicina Tropical Daniel A. Carrion, Faculty of Medicine, UNMSM,Lima, Peru. Study material: IgE antibody ELISA test. Interventions: IgE antibody ELISA test standardization with preexperimentalpretest and post test in one group to assess its value in diagnosis and post-treatment of patients with hepatic hydatid cysts treatedwith albendazole. For ELISA test standardization we used serum from five patients with clinical and immunological diagnosis ofcystic echinococcosis; to test sensitivity and specificity sera of 30 apparently healthy subjects were studied; to determine crossreactions16 serum samples from patients with other helminth infections (ascariasis, strongiloidiasis, toxocariasis, trichuriasis,hymenolepiasis cysticercosis and taeniasis) were used. For diagnosis and post-treatment evaluation of cystic echinocococosisserum from 17 patients was studied. Main outcome measures: Standarized ELISA test sensitivity and specificity to detect IgEantibodies. Results: Sensitivity and specificity of standardized ELISA test to detect IgE antibody were respectively 95.6% and 100%.Patients with hepatic hydatid cyst considered cured uniformly showed lower levels of IgE antibody even to negativization. There wasincrease of IgE levels in patients who had recurrence of hepatic cystic disease. Conclusions: This study found excellent sensitivity andspecificity of ELISA test for cystic echinococcosis IgE antibodies. Healing of cysts coincided with progressive decrease in IgE levelsthat could reach negativization after one year post-treatment and was useful to detect recurrence. Persistence of IgE high levels inpatients treated medically was indicative of no response to treatment. As sample size was not large, it seems necessary to continueinvestigation to confirm these results.Objetivos: Determinar las diluciones y concentraciones optimas de una prueba de ELISA para detectar anticuerpos IgE, así como su sensibilidad, espécificidad y valor predictivo en pacientes con equinococosis quistica. Analizar si los niveles de anticuerpos IgE especificos se correlacionan con la respuesta al tratamiento médico con albendazol en un periodo mayor a un año de finalizado el tratamiento. Diseño: Estudio cuasiexperimental con grupo control. Institución: Instituto de Medicina Tropical Daniel A. Carrión, Facultad de Medicina, UNMSM, Lima, Perú. Material de estudio: Prueba de ELISA para anticuerpo IgE. Intervenciones: Estandarizacion de la prueba de ELISA para anticuerpo IgE y diseño preexperimento con preprueba y posprueba en un solo grupo, para evaluar su valor en el diagnóstico y seguimiento postratamiento de pacientes con quiste hidatidico hepatico tratados con albendazol. Para la estandarizacion de la prueba de ELISA, se utilizó suero de cinco pacientes con diagnóstico clínico de equinococosis quistica, y la sensibilidad y especificidad de la prueba se usó suero de 30 pacientes aparentemente sanos. Para determinar las reacciones cruzadas, se utilizó 16 muestras de suero de pacientes con otras helmintiasis (ascariasis, strongiloidiasis, toxocariosis, trichuriasis, himenolepiasis, cisticercosis y teniasis). Para el diagnóstico y seguimiento postratamiento de equinocococosis quística, se utilizó el suero de 17 pacientes. Principales medidas de resultados: Sensibilidad y especificidad de prueba estandarizada de ELISA para detectar anticuerpos IgE. Resultados: La prueba estandarizada de ELISA para detectar anticuerpos IgE tuvo una sensibilidad de 95,6% y una especificidad de 100%. En los pacientes con quiste hidatídico hepático considerados curados, uniformemente disminuyeron los niveles de anticuerpo tipo IgE hasta la negativización. Se obtuvo elevación de los niveles de IgE en los pacientes que presentaron recurrencia de la enfermedad quística hepática. Conclusiones: En el presente estudio se encontró un excelente nivel de sensibilidad y especificidad de la prueba de ELISA para anticuerpos IgE de equinococosis quística. La curación de los quistes coincidió con una dismuinución progresiva de los niveles de IgE, que pudo llegar a la negativización después de un año postratamiento y fue de gran utilidad para detectar la recurrencia. La persistencia de niveles elevados de IgE en pacientes tratados médicamente fue indicativo de no haber respuesta al tratamiento. Siendo no muy grande el tamaño de la muestra de nuestro estudio, es necesario continuar con la investigación para confirmar estos resultados.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2012-03-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionmedicina tropicalapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/80810.15381/anales.v73i1.808Anales de la Facultad de Medicina; Vol. 73 No. 1 (2012); 35-41Anales de la Facultad de Medicina; Vol. 73 Núm. 1 (2012); 35-411609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/808/645Derechos de autor 2012 Herman Vildózola, Irma Espinoza, William H. Roldanhttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:revistasinvestigacion.unmsm.edu.pe:article/8082020-04-15T19:35:15Z
score 13.881323
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).